CEI

N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE

Created:	2004-01-26
Last modified:	2021-03-01

Find Related PDB Entry
12 entries where CEI is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	0
Bond Count	55
Aromatic Bond Count	25

2D diagram of CEI

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE
Synonyms	COELENTERAMIDE
Systematic Name (OpenEye OEToolkits)	2-(4-hydroxyphenyl)-N-[5-(4-hydroxyphenyl)-3-(phenylmethyl)pyrazin-2-yl]ethanamide
Formula	C₂₅ H₂₁ N₃ O₃
Molecular Weight	411.453
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(Nc1ncc(nc1Cc2ccccc2)c3ccc(O)cc3)Cc4ccc(O)cc4
SMILES	CACTVS	3.341	Oc1ccc(CC(=O)Nc2ncc(nc2Cc3ccccc3)c4ccc(O)cc4)cc1
SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)Cc2c(ncc(n2)c3ccc(cc3)O)NC(=O)Cc4ccc(cc4)O
Canonical SMILES	CACTVS	3.341	Oc1ccc(CC(=O)Nc2ncc(nc2Cc3ccccc3)c4ccc(O)cc4)cc1
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)Cc2c(ncc(n2)c3ccc(cc3)O)NC(=O)Cc4ccc(cc4)O
InChI	InChI	1.03	InChI=1S/C25H21N3O3/c29-20-10-6-18(7-11-20)15-24(31)28-25-22(14-17-4-2-1-3-5-17)27-23(16-26-25)19-8-12-21(30)13-9-19/h1-13,16,29-30H,14-15H2,(H,26,28,31)
InChIKey	InChI	1.03	CJIIERPDFZUYPI-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB04049
Name	Coelenteramide
Groups	experimental
Synonyms	Coelenteramide
Categories	Acetamides Amides Benzene Derivatives

Related Resource References

Resource Name	Reference
PubChem	448487
ChEBI	CHEBI:41487

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.